| 
																	
																		 
																		 Technology Assessment, Biomedical
 
																		 
																		
																	 
																		 
																		
																	 
																			
																					
	"Technology Assessment, Biomedical" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
 
	
	
		
			
			
				Evaluation of biomedical technology in relation to cost, efficacy, utilization, etc., and its future impact on social, ethical, and legal systems.
    
			 
				
				
					
						| Descriptor ID | D013673 |  
						| MeSH Number(s) | N03.880 N05.715.360.825 |  
						| Concept/Terms | Technology Assessment, BiomedicalTechnology Assessment, BiomedicalBiomedical Technology AssessmentTechnology Assessment, HealthAssessment, Health TechnologyAssessments, Health TechnologyHealth Technology AssessmentHealth Technology AssessmentsTechnology Assessments, HealthAssessment, Biomedical TechnologyAssessments, Biomedical TechnologyBiomedical Technology AssessmentsTechnology Assessments, Biomedical
 Technology AssessmentTechnology AssessmentAssessment, TechnologyAssessments, TechnologyTechnology Assessments
 |  
				Below are MeSH descriptors whose meaning is more general than "Technology Assessment, Biomedical". 
				Below are MeSH descriptors whose meaning is more specific than "Technology Assessment, Biomedical". 
	
	
		
			
			
					
				This graph shows the total number of publications written about "Technology Assessment, Biomedical" by people in this website by year, and whether "Technology Assessment, Biomedical" was a major or minor topic of these publications.  
					  To see the data from this visualization as text, click here. 
		            | Year | Major Topic | Minor Topic | Total | 
|---|
 | 1995 | 0 | 4 | 4 |  | 1997 | 1 | 0 | 1 |  | 1998 | 0 | 1 | 1 |  | 2005 | 1 | 1 | 2 |  | 2007 | 0 | 4 | 4 |  | 2008 | 1 | 0 | 1 |  | 2010 | 0 | 2 | 2 |  | 2013 | 1 | 0 | 1 |  | 2014 | 0 | 1 | 1 |  | 2015 | 0 | 1 | 1 |  | 2016 | 1 | 1 | 2 |  | 2017 | 0 | 1 | 1 |  | 2019 | 1 | 0 | 1 |  | 2020 | 0 | 1 | 1 |  | 2022 | 3 | 1 | 4 |  | 2023 | 1 | 1 | 2 |  | 2024 | 0 | 2 | 2 | 
 
                    To return to the timeline, click here. 
				Below are the most recent publications written about "Technology Assessment, Biomedical" by people in Profiles. 		
					
								
								Beard DJ, Davies L, Cook JA, Stokes J, Leal J, Fletcher H, Abram S, Chegwin K, Greshon A, Jackson W, Bottomley N, Dodd M, Bourke H, Shirkey BA, Paez A, Lamb SE, Barker KL, Phillips M, Brown M, Lythe V, Mirza B, Carr A, Monk P, Areia CM, O'Leary S, Haddad F, Wilson C, Price A. Comparison of surgical or non-surgical management for non-acute anterior cruciate ligament injury: the ACL SNNAP RCT. Health Technol Assess. 2024 06; 28(27):1-97.
								DiStefano MJ, Pearson SD, Rind DM, Zemplenyi A. How Do the Institute for Clinical and Economic Review's Assessments of Comparative Effectiveness Compare With the German Federal Joint Committee's Assessments of Added Benefit? A Qualitative Study. Value Health. 2024 08; 27(8):1066-1072.
								Charlton V, DiStefano M, Mitchell P, Morrell L, Rand L, Badano G, Baker R, Calnan M, Chalkidou K, Culyer A, Howdon D, Hughes D, Lomas J, Max C, McCabe C, O'Mahony JF, Paulden M, Pemberton-Whiteley Z, Rid A, Scuffham P, Sculpher M, Shah K, Weale A, Wester G. We need to talk about values: a proposed framework for the articulation of normative reasoning in health technology assessment. Health Econ Policy Law. 2024 04; 19(2):153-173.
								DiStefano MJ, Karim SA, Krubiner CB, Hofman KJ. Integrating Health Technology Assessment and the Right to Health in South Africa: A Qualitative Content Analysis of Substantive Values in Landmark Judicial Decisions. J Law Med Ethics. 2023; 51(1):131-149.
								DiStefano MJ. Moral and Social Values in Evidence-Informed Deliberative Processes for Health Benefit Package Design Comment on "Evidence-Informed Deliberative Processes for Health Benefit Package Design - Part II: A Practical Guide". Int J Health Policy Manag. 2023; 12:7480.
								Mendola ND, Oehrlein E, Perfetto EM, Westrich K, McQueen RB. Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States. J Manag Care Spec Pharm. 2022 Oct; 28(10):1190-1196.
								DiStefano MJ, Abdool Karim S, Krubiner CB. Integrating health technology assessment and the right to health: a qualitative content analysis of procedural values in South African judicial decisions. Health Policy Plan. 2022 May 12; 37(5):644-654.
								Krubiner CB, Barsdorf NW, Goldstein SJ, Mosam A, Potgieter S, DiStefano MJ, Tugendhaft A, Merritt MW, Li R, Chalkidou K, Faden RR, Hofman KJ. Developing and piloting a context-specified ethics framework for health technology assessment: the South African Values and Ethics for Universal Health Coverage approach. Int J Technol Assess Health Care. 2022 Mar 08; 38(1):e26.
								Day C, Briskman J, Crawford MJ, Foote L, Harris L, Boadu J, McCrone P, McMurran M, Michelson D, Moran P, Mosse L, Scott S, Stahl D, Ramchandani P, Weaver T. An intervention for parents with severe personality difficulties whose children have mental health problems: a feasibility RCT. Health Technol Assess. 2020 03; 24(14):1-188.
								Liu G, Wu EQ, Ahn J, Kamae I, Xie J, Yang H. The Development of Health Technology Assessment in Asia: Current Status and Future Trends. Value Health Reg Issues. 2020 May; 21:39-44. | 
																	
																		
																			
																					People  People who have written about this concept._ 
    
        Similar Concepts   
        People who have written about this concept.
     _ 
    
        Top Journals   
        Top journals in which articles about this concept have been published.
     |